Transplantation with GXHPC1 for Liver Cirrhosis: Phase 1 Trial

Currently, the only effective therapy for cirrhosis of the liver is liver transplantation. However, finding a compatible liver is difficult due to the low supply of healthy livers and the ever-increasing demand. However, stem-cell therapy may offer a solution for liver cirrhosis; for example, GXHPC1...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ko-Chang, Chuang, Ming-Hsi, Lin, Zung-Sheng, Lin, Yi-Chun, Chen, Chun-Hung, Chang, Chao-Liang, Huang, Pi-Chun, Syu, Wan-Sin, Chiou, Tzyy-Wen, Hong, Zih-Han, Tsai, Yu-Chen, Harn, Horng-Jyh, Lin, Po-Cheng, Lin, Shinn-Zong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016466/
https://www.ncbi.nlm.nih.gov/pubmed/31722556
http://dx.doi.org/10.1177/0963689719884885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016466/
https://www.ncbi.nlm.nih.gov/pubmed/31722556
http://dx.doi.org/10.1177/0963689719884885

Ejemplares similares